Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01156298 · ClinicalTrials.gov registry record
Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance
A clinical trial, sponsored by Biogen.
- Terminated
- Registry status
- 383
- Enrollment target
NCT01156298 is a clinical trial that was terminated before completion, run by Biogen. The registered enrollment target is 383 participants.
The verdict
NCT01156298 was terminated before completion, sponsored by Biogen.
- TERMINATED
- Registry status
- 383 participants
- Enrollment target
Study Summary
Phase IV, multi-center, non-treatment, observational, registry study to determine long term effects of AVONEX® therapy on EDSS, MRI, QoL, and cognition.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 383 participants |
| Start Date | 2010-06 |
| Est. Completion | 2017-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01156298
The ClinicalTrials.gov registry entry for NCT01156298 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 383 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01156298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01156298 about?
NCT01156298 is a clinical study titled "Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological Surveillance". Phase IV, multi-center, non-treatment, observational, registry study to determine long term effects of AVONEX® therapy on EDSS, MRI, QoL, and cognition.
What is the current status of trial NCT01156298?
This trial is currently terminated. The enrollment target is 383 participants. The study started on 2010-06. Estimated completion is 2017-03.
Who is sponsoring clinical trial NCT01156298?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.